CA2771373A1 — Reminder device for drug delivery devices
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2011-03-03 · 15y expired
What this patent protects
The present invention relates to a reminder device for a drug delivery device (10), comprising: a base member (12, 14), - an adjusting element (22; 36) movably disposed with respect to the base member (12, 14) between at least two stop positions, and a display means (18; 28) comp…
USPTO Abstract
The present invention relates to a reminder device for a drug delivery device (10), comprising: a base member (12, 14), - an adjusting element (22; 36) movably disposed with respect to the base member (12, 14) between at least two stop positions, and a display means (18; 28) comprising an information surface (26; 40) being only partially discernible through an aperture (30; 38), wherein at least two designated segments (25, 27) of the information surface (26; 40) become selectively discernible by a displacement of the adjusting element (22; 26) relative to the base member (12, 14).
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.